Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses

Area of Science:

• Neuroimmunology
• Neuroinflammation
• Autoimmune Diseases

Background:

• Pathogen invasion triggers Toll-like receptor activation, leading to proinflammatory cytokines and glial cell activation (microglia and astrocytes).
• Neuroinflammatory, autoimmune diseases (e.g., MS, Parkinson's, lupus), and Chronic Fatigue Syndrome (CFS) share symptoms of severe fatigue and disability.
• Patients exhibit peripheral immune activation, systemic inflammation, elevated cytokines, oxidative stress, and activated Toll-like receptors.

Purpose of the Study:

• To explore the link between peripheral immune activation, inflammation, and neurological dysfunction in debilitating fatigue syndromes.
• To investigate the role of glial cells and mitochondrial dysfunction in fatigue associated with neuroimmune and autoimmune diseases.

Main Methods:

• Review of evidence associating peripheral immune activation, inflammation, and oxidative stress with neurological changes.
• Examination of the impact of peripheral inflammation on astrocyte function.
• Consideration of FLAIR MRI and peripheral immune activation testing for idiopathic fatigue.

Main Results:

• Peripheral immune activation, inflammation, and oxidative stress correlate with gray matter atrophy, hypometabolism, and hypoperfusion in diseases like MS, Parkinson's, and CFS.
• Reduced astrocyte numbers and function, secondary to inflammation, likely explain observed abnormalities.
• Widespread mitochondrial dysfunction is evident in neuroinflammatory, neurodegenerative, and autoimmune diseases, as well as in CFS.

Conclusions:

• Peripheral inflammation, immune activation, glial cell activation, and mitochondrial damage are key contributors to severe fatigue and disability in neuroimmune and autoimmune diseases.
• These mechanisms are also implicated in the pathophysiology of Chronic Fatigue Syndrome.
• Patients with disabling, idiopathic fatigue should be evaluated for peripheral immune activation and neuroinflammation.